2,303 results on '"Thomas Craig"'
Search Results
2. Factors Affecting Initiation and Retention of Medication-Assisted Recovery (MAR) within a Pilot Pharmacist-Involved Practice Model at a Federally Qualified Healthcare Center (FQHC) during the COVID-19 Pandemic
- Author
-
Tiffany Nguyen, Thomas Craig Cheetham, Souhiela Fawaz, Richard Beuttler, and Sharon Xavioer
- Subjects
Medication-Assisted Treatment ,buprenorphine ,MAT program ,initiation ,retention ,Medication-Assisted Recovery ,Medicine - Abstract
Background: During the COVID-19 pandemic, opioid-related overdose deaths increased. Although Medication-Assisted Treatment or Recovery (MAT or MAR) is available, initiation and retention rates vary. The goal of this study was to evaluate clinical, demographic, and Social Determinant of Health factors affecting MAR initiation, on-time initiation of medications, and successful retention in the program. The secondary goal was to evaluate the impact of a novel interprofessional practice model incorporating pharmacists. Methods: A retrospective analysis was conducted using electronic health record data from a pilot MAR Program initiated within a California Federally Qualified Healthcare Center. Results: From September 2019 to August 2020, 48 patients enrolled into the program. On-time initiation of medications occurred in 68% of patients and average program retention was 96.4 ± 95.8 days. Patients currently using opioids (p = 0.005) and those receiving supportive medications (p = 0.049) had lower odds of on-time MAR initiation. There were no statistically significant factors associated with successful retention in the program. The number of visits with members of the interprofessional team did not significantly affect on-time initiation or successful retention. Conclusions: Current opioid use and receipt of supportive medications were associated with lower on-time medication initiation. Further studies are warranted to explore additional factors which may affect initiation and retention.
- Published
- 2023
- Full Text
- View/download PDF
3. Optimising AVATAR therapy for people who hear distressing voices: study protocol for the AVATAR2 multi-centre randomised controlled trial
- Author
-
Philippa Garety, Clementine J. Edwards, Thomas Ward, Richard Emsley, Mark Huckvale, Paul McCrone, Mar Rus-Calafell, Miriam Fornells-Ambrojo, Andrew Gumley, Gillian Haddock, Sandra Bucci, Hamish McLeod, Amy Hardy, Emmanuelle Peters, Inez Myin-Germeys, and Thomas Craig
- Subjects
Auditory hallucinations ,Psychosis ,Psychological intervention ,Digital health technology ,Randomised controlled trial ,Medicine (General) ,R5-920 - Abstract
Abstract Background AVATAR therapy is a novel intervention targeting distressing auditory verbal hallucinations (henceforth ‘voices’). A digital simulation (avatar) of the voice is created and used in a three-way dialogue between participant, avatar and therapist. To date, therapy has been delivered over 6 sessions, comprising an initial phase, focusing on standing up to a hostile avatar, and a second phase in which the avatar concedes and focus shifts to individualised treatment targets, including beliefs about voices. The first fully powered randomised trial found AVATAR therapy resulted in a rapid and substantial fall in voice frequency and associated distress that was superior to supportive counselling at 12 weeks. The main objective of this AVATAR2 trial is to test the efficacy of two forms of AVATAR therapy in reducing voice-related distress: AVATAR-brief (standardised focus on exposure, assertiveness and self-esteem) and AVATAR-extended (phase 1 mirroring AVATAR-brief augmented by a formulation-driven phase 2). Secondary objectives include the examination of additional voice, wellbeing and mood outcomes, the exploration of mediators and moderators of therapy response, and examining cost-effectiveness of both forms of therapy compared with usual treatment (TAU). Methods This multi-site parallel group randomised controlled trial will independently randomise 345 individuals to receive AVATAR-brief (6 sessions) plus TAU or AVATAR-extended (12 sessions) plus TAU or TAU alone (1:1:1 allocation). Participants will be people with a diagnosis of schizophrenia spectrum and other psychotic disorders who have heard distressing voices for more than 6 months. The primary outcome is the PSYRATS Auditory Hallucinations Distress dimension score at 16 and 28 weeks, conducted by blinded assessors. Statistical analysis will follow the intention-to-treat principle and data will be analysed using linear mixed models. Mediation and moderation analyses using contemporary causal inference methods will be conducted as secondary analyses. Service costs will be calculated, and cost-effectiveness assessed in terms of quality-adjusted life years accrued. Discussion This study will clarify optimal therapy delivery, test efficacy in a multi-site study and enable the testing of the AVATAR software platform, therapy training and provision in NHS settings. Trial registration ISRCTN registry ISRCTN55682735 . Registered on 22 January 2020. The trial is funded by the Wellcome Trust (WT).
- Published
- 2021
- Full Text
- View/download PDF
4. Clinical and cost-effectiveness of contingency management for cannabis use in early psychosis: the CIRCLE randomised clinical trial
- Author
-
Luke Sheridan Rains, Louise Marston, Mark Hinton, Steven Marwaha, Thomas Craig, David Fowler, Michael King, Rumana Z. Omar, Paul McCrone, Jonathan Spencer, Joanne Taylor, Sophie Colman, Catherine Harder, Eleanor Gilbert, Amie Randhawa, Kirsty Labuschagne, Charlotte Jones, Theodora Stefanidou, Marina Christoforou, Meghan Craig, John Strang, Tim Weaver, and Sonia Johnson
- Subjects
Financial incentives ,Contingency management ,Cannabis ,Psychosis ,Early intervention ,Substance misuse ,Medicine - Abstract
Abstract Background Cannabis is the most commonly used illicit substance amongst people with psychosis. Continued cannabis use following the onset of psychosis is associated with poorer functional and clinical outcomes. However, finding effective ways of intervening has been very challenging. We examined the clinical and cost-effectiveness of adjunctive contingency management (CM), which involves incentives for abstinence from cannabis use, in people with a recent diagnosis of psychosis. Methods CIRCLE was a pragmatic multi-centre randomised controlled trial. Participants were recruited via Early Intervention in Psychosis (EIP) services across the Midlands and South East of England. They had had at least one episode of clinically diagnosed psychosis (affective or non-affective); were aged 18 to 36; reported cannabis use in at least 12 out of the previous 24 weeks; and were not currently receiving treatment for cannabis misuse, or subject to a legal requirement for cannabis testing. Participants were randomised via a secure web-based service 1:1 to either an experimental arm, involving 12 weeks of CM plus a six-session psychoeducation package, or a control arm receiving the psychoeducation package only. The total potential voucher reward in the CM intervention was £240. The primary outcome was time to acute psychiatric care, operationalised as admission to an acute mental health service (including community alternatives to admission). Primary outcome data were collected from patient records at 18 months post-consent by assessors masked to allocation. The trial was registered with the ISRCTN registry, number ISRCTN33576045. Results Five hundred fifty-one participants were recruited between June 2012 and April 2016. Primary outcome data were obtained for 272 (98%) in the CM (experimental) group and 259 (95%) in the control group. There was no statistically significant difference in time to acute psychiatric care (the primary outcome) (HR 1.03, 95% CI 0.76, 1.40) between groups. By 18 months, 90 (33%) of participants in the CM group, and 85 (30%) of the control groups had been admitted at least once to an acute psychiatric service. Amongst those who had experienced an acute psychiatric admission, the median time to admission was 196 days (IQR 82, 364) in the CM group and 245 days (IQR 99, 382) in the control group. Cost-effectiveness analyses suggest that there is an 81% likelihood that the intervention was cost-effective, mainly resulting from higher mean inpatient costs for the control group compared with the CM group; however, the cost difference between groups was not statistically significant. There were 58 adverse events, 27 in the CM group and 31 in the control group. Conclusions Overall, these results suggest that CM is not an effective intervention for improving the time to acute psychiatric admission or reducing cannabis use in psychosis, at least at the level of voucher reward offered.
- Published
- 2019
- Full Text
- View/download PDF
5. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT
- Author
-
Sonia Johnson, Luke Sheridan Rains, Steven Marwaha, John Strang, Thomas Craig, Tim Weaver, Paul McCrone, Michael King, David Fowler, Stephen Pilling, Louise Marston, Rumana Z Omar, Meghan Craig, Jonathan Spencer, and Mark Hinton
- Subjects
FINANCIAL INCENTIVES ,CONTINGENCY MANAGEMENT ,CANNABIS ,PSYCHOSIS ,EARLY INTERVENTION ,SUBSTANCE MISUSE ,Medical technology ,R855-855.5 - Abstract
Background: Cannabis is the most prevalent illicit substance among people with psychosis, and its use is associated with poorer clinical and social outcomes. However, so far, there has been limited evidence that any treatment is effective for reducing use. Contingency management (CM) is an incentive-based intervention for substance misuse that has a substantial evidence base across a range of substances and cohorts. However, to date there have been no randomised controlled trials (RCTs) of CM as a treatment for cannabis use specifically in psychosis. Objective: To conduct a RCT investigating the clinical effectiveness and cost-effectiveness of CM in reducing cannabis use among Early Intervention in Psychosis (EIP) service users. Design: The CIRCLE (Contingency Intervention for Reduction of Cannabis in Early Psychosis) trial was a rater-blinded, multicentre RCT with two arms. Participants were randomised 1 : 1 to either an CM arm, in which participants received CM for cannabis use alongside an optimised treatment-as-usual programme including structured psychoeducation, or a control arm in which participants received the treatment as usual only. Setting: EIP services across the Midlands and the south-east of England. Participants: The main eligibility criteria were EIP service users with a history of psychosis, aged 18–36 years, and having used cannabis at least once per week during 12 of the previous 24 weeks. Intervention: The CM intervention offered financial incentives (i.e. shopping vouchers) for cannabis abstinence over 12 once-weekly sessions, confirmed using urinalysis. The maximum value in vouchers that participants could receive was £240. Main outcome measures: The main outcome was time to relapse, operationalised as admission to an acute mental health service or hospital. The primary outcome was assessed at 18 months post inclusion using electronic patient records. Secondary outcomes assessed the clinical effectiveness and cost-effectiveness of the intervention, for which data were collected at 3 and 18 months. Results: A total of 278 participants were randomised to the CM arm and 273 were randomised to the control arm. In total, 530 (96%) participants were followed up for the primary outcome. There was no significant difference in time to admission between trial arms by 18 months following consent (hazard ratio 1.03, 95% confidence interval 0.76 to 1.40). There were no statistically significant differences in most secondary outcomes, including cannabis use, at either follow-up assessment. There were 58 serious adverse events, comprising 52 inpatient episodes, five deaths and one arrest. Limitations: Participant retention was low at 18 months, limiting the assessment of secondary outcomes. A different CM intervention design or reward level may have been effective. Conclusions: The CM intervention did not appear to be effective in reducing cannabis use and acute relapse among people with early psychosis and problematic cannabis use. Future work: Cannabis use is still a significant clinical concern in this population. A pressing need remains to identify suitable treatments. A wider perspective on the social circumstances of young people with psychosis may be needed for a successful intervention to be found. Trial registration: Current Controlled Trials ISRCTN33576045. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 45. See the NIHR Journals Library website for further project information.
- Published
- 2019
- Full Text
- View/download PDF
6. Primary care management of cardiovascular risk for people with severe mental illnesses: the Primrose research programme including cluster RCT
- Author
-
David Osborn, Alexandra Burton, Kate Walters, Lou Atkins, Thomas Barnes, Ruth Blackburn, Thomas Craig, Hazel Gilbert, Ben Gray, Sarah Hardoon, Samira Heinkel, Richard Holt, Rachael Hunter, Claire Johnston, Michael King, Judy Leibowitz, Louise Marston, Susan Michie, Richard Morris, Steve Morris, Irwin Nazareth, Rumana Omar, Irene Petersen, Robert Peveler, Vanessa Pinfold, Fiona Stevenson, and Ella Zomer
- Subjects
severe mental illness ,schizophrenia ,bipolar ,psychosis ,primary care ,general practice ,statin ,cholesterol ,cardiovascular risk ,randomised controlled trial ,risk score ,qualitative ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Effective interventions are needed to prevent cardiovascular disease (CVD) in people with severe mental illnesses (SMI) because their risk of CVD is higher than that of the general population. Objectives: (1) Develop and validate risk models for predicting CVD events in people with SMI and evaluate their cost-effectiveness, (2) develop an intervention to reduce levels of cholesterol and CVD risk in SMI and (3) test the clinical effectiveness and cost-effectiveness of this new intervention in primary care. Design: Mixed methods with patient and public involvement throughout. The mixed methods were (1) a prospective cohort and risk score validation study and cost-effectiveness modelling, (2) development work (focus groups, updated systematic review of interventions, primary care database studies investigating statin prescribing and effectiveness) and (3) cluster randomised controlled trial (RCT) assessing the clinical effectiveness and cost-effectiveness of a new practitioner-led intervention, and fidelity assessment of audio-recorded appointments. Setting: General practices across England. Participants: All studies included adults with SMI (schizophrenia, bipolar disorder or other non-organic psychosis). The RCT included adults with SMI and two or more CVD risk factors. Interventions: The intervention consisted of 8–12 appointments with a practice nurse/health-care assistant over 6 months, involving collaborative behavioural approaches to CVD risk factors. The intervention was compared with routine practice with a general practitioner (GP). Main outcome measures: The primary outcome for the risk score work was CVD events, in the cost-effectiveness modelling it was quality-adjusted life-years (QALYs) and in the RCT it was level of total cholesterol. Data sources: Databases studies used The Health Improvement Network (THIN). Intervention development work included focus groups and systematic reviews. The RCT collected patient self-reported and routine NHS GP data. Intervention appointments were audio-recorded. Results: Two CVD risk score models were developed and validated in 38,824 people with SMI in THIN: the Primrose lipid model requiring cholesterol levels, and the Primrose body mass index (BMI) model with no blood test. These models performed better than published Cox Framingham models. In health economic modelling, the Primrose BMI model was most cost-effective when used as an algorithm to drive statin prescriptions. Focus groups identified barriers to, and facilitators of, reducing CVD risk in SMI including patient engagement and motivation, staff confidence, involving supportive others, goal-setting and continuity of care. Findings were synthesised with evidence from updated systematic reviews to create the Primrose intervention and training programme. THIN cohort studies in 16,854 people with SMI demonstrated that statins effectively reduced levels of cholesterol, with similar effect sizes to those in general population studies over 12–24 months (mean decrease 1.2 mmol/l). Cluster RCT: 76 GP practices were randomised to the Primrose intervention (n = 38) or treatment as usual (TAU) (n = 38). The primary outcome (level of cholesterol) was analysed for 137 out of 155 participants in Primrose and 152 out of 172 in TAU. There was no difference in levels of cholesterol at 12 months [5.4 mmol/l Primrose vs. 5.5 mmol/l TAU; coefficient 0.03; 95% confidence interval (CI) –0.22 to 0.29], nor in secondary outcomes related to cardiometabolic parameters, well-being or medication adherence. Mean cholesterol levels decreased over 12 months in both arms (–0.22 mmol/l Primrose vs. –0.39 mmol/l TAU). There was a significant reduction in the cost of inpatient mental health attendances (–£799, 95% CI –£1480 to –£117) and total health-care costs (–£895, 95% CI –£1631 to –£160; p = 0.012) in the intervention group, but no significant difference in QALYs (–0.011, 95% CI –0.034 to 0.011). A total of 69% of patients attended two or more Primrose appointments. Audiotapes revealed moderate fidelity to intervention delivery (67.7%). Statin prescribing and adherence was rarely addressed. Limitations: RCT participants and practices may not represent all UK practices. CVD care in the TAU arm may have been enhanced by trial procedures involving CVD risk screening and feedback. Conclusions: SMI-specific CVD risk scores better predict new CVD if used to guide statin prescribing in SMI. Statins are effective in reducing levels of cholesterol in people with SMI in UK clinical practice. This primary care RCT evaluated an evidence-based practitioner-led intervention that was well attended by patients and intervention components were delivered. No superiority was shown for the new intervention over TAU for level of cholesterol, but cholesterol levels decreased over 12 months in both arms and the intervention showed fewer inpatient admissions. There was no difference in cholesterol levels between the intervention and TAU arms, which might reflect better than standard general practice care in TAU, heterogeneity in intervention delivery or suboptimal emphasis on statins. Future work: The new risk score should be updated, deployed and tested in different settings and compared with the latest versions of CVD risk scores in different countries. Future research on CVD risk interventions should emphasise statin prescriptions more. The mechanism behind lower costs with the Primrose intervention needs exploring, including SMI-related training and offering frequent support to people with SMI in primary care. Trial registration: Current Controlled Trials ISRCTN13762819. Funding: This project was funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 7, No. 2. See the NIHR Journals Library website for further project information. Professor David Osborn is supported by the University College London Hospital NIHR Biomedical Research Centre and he was also in part supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust.
- Published
- 2019
- Full Text
- View/download PDF
7. Patient involvement in improving the evidence base on mental health inpatient care: the PERCEIVE programme
- Author
-
Til Wykes, Emese Csipke, Diana Rose, Thomas Craig, Paul McCrone, Paul Williams, Leonardo Koeser, and Stephen Nash
- Subjects
inpatient care ,psychological treatment ,patient involvement ,perceptions of care ,patient views of care ,staff views of care ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Despite the movement towards care in the community, 40% of the NHS budget on mental health care is still attributed to inpatient services. However, long before the Francis Report highlighted grave shortcomings in inpatient care, there were reports by service user groups on the poor quality of these services in mental health. The programme provides a particular focus on the inclusion of the patient’s perspective in the development and evaluation of evidence. Objectives: To understand how changes to inpatient care affect the perceptions of the ward by service users and staff by using stakeholder participatory methods. Design: The programme consisted of four work packages (WPs). (1) Lasting Improvements for Acute Inpatient SEttings (LIAISE): using participatory methods we developed two new scales [Views On Therapeutic Environment (VOTE) for staff and Views On Inpatient CarE (VOICE) for service users]. (2) Client Services Receipt Inventory – Inpatient (CITRINE): working with nurses and service users we developed a health economic measure of the amount of contact service users have with staff. The self-report measure records interactions with staff as well as the number of therapeutic activities attended. (3) Delivering Opportunities for Recovery (DOORWAYS): a stepped-wedge randomised controlled trial to test if training ward nurses to deliver therapeutic group activities would improve the perception of the ward by service users and staff. A total of 16 wards were progressively randomised and we compared the VOICE, VOTE and CITRINE measures before and after the intervention. A total of 1108 service users and 539 staff participated in this trial. (4) Bringing Emergency TreatmenT to Early Resolution (BETTER PATHWAYS) was an observational study comparing two service systems. The first was a ‘triage’ system in which service users were admitted to the triage ward and then either transferred to their locality wards or discharged back into the community within 7 days. The second system was routine care. We collected data from 454 service users and 284 nurses on their perceptions of the wards. Main outcome measures: The main outcomes for the DOORWAYS and BETTER project were service user and staff perceptions of the ward (VOICE and VOTE, respectively) and the health economic measure was CITRINE. All were developed in WPs 1 and 2. Results: We developed reliable and valid measures of (1) the perceptions of inpatient care from the perspectives of service users and nurses (VOICE and VOTE) and (2) costs of interactions that were valued by service users (CITRINE). In the DOORWAYS project, after adjusting for legal status, we found weak evidence for benefit (standardised effect of –0.18, 95% CI 0.38 improvement to 0.01 deterioration; p = 0.062). There was only a significant benefit for involuntary patients following the staff training (N582, standardised effect of –0.35, 95% CI –0.57 to –0.12; p = 0.002; interaction p-value 0.006). VOTE scores did not change over time (standardised effect size of 0.04, 95% CI –0.09 to 0.18; p = 0.54). We found no evidence of an improvement in cost-effectiveness (estimated effect of £33, 95% CI –£91 to £146; p = 0.602), but resource allocation did change towards patient-perceived meaningful contacts by an average of £12 (95% CI –£76 to £98; p = 0·774). There were no significant differences between the triage and routine models of admission in terms of better perceptions by service users (estimated effect 0.77-point improvement in VOICE score on the triage ward; p = 0.68) or nurses (estimated effect of 1.68-point deterioration in VOTE on the triage ward; p = 0.38) or in terms of the cost of the length of care provided (£391 higher on triage; p = 0.77). Strengths and limitations: We have developed measures using methods involving both service users and staff from mental health services. The measures were developed specifically for acute inpatient services and, therefore, cannot be assumed to be useful for other services. For instance, extensions of the measures are under construction for use in mother and baby units. The strength of the BETTER PATHWAYS and DOORWAYS projects is the large-scale data collection. However, we were testing specific services based in inner city areas and stretching to inner urban areas. It may be that different effects would be found in more rural communities or in different types of inpatient care. Future work: Our database will be used to develop an understanding of the mediating and moderating factors for improving care quality. Trial registration: Current Controlled Trials ISRCTN06545047. Funding: This project was funded by the NIHR Programme Grants for Applied Research programme and will be published in full in Programme Grants for Applied Research; Vol. 6, No. 7. See the NIHR Journals Library website for further project information.
- Published
- 2018
- Full Text
- View/download PDF
8. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors
- Author
-
Sinha, Sanju, Vegesna, Rahulsimham, Mukherjee, Sumit, Kammula, Ashwin V., Dhruba, Saugato Rahman, Wu, Wei, Kerr, D. Lucas, Nair, Nishanth Ulhas, Jones, Matthew G., Yosef, Nir, Stroganov, Oleg V., Grishagin, Ivan, Aldape, Kenneth D., Blakely, Collin M., Jiang, Peng, Thomas, Craig J., Benes, Cyril H., Bivona, Trever G., Schäffer, Alejandro A., and Ruppin, Eytan
- Published
- 2024
- Full Text
- View/download PDF
9. High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma
- Author
-
Arang, Nadia, Lubrano, Simone, Ceribelli, Michele, Rigiracciolo, Damiano C, Saddawi-Konefka, Robert, Faraji, Farhoud, Ramirez, Sydney I, Kim, Daehwan, Tosto, Frances A, Stevenson, Erica, Zhou, Yuan, Wang, Zhiyong, Bogomolovas, Julius, Molinolo, Alfredo A, Swaney, Danielle L, Krogan, Nevan J, Yang, Jing, Coma, Silvia, Pachter, Jonathan A, Aplin, Andrew E, Alessi, Dario R, Thomas, Craig J, and Gutkind, J Silvio
- Subjects
Biomedical and Clinical Sciences ,Rare Diseases ,Cancer ,Eye Disease and Disorders of Vision ,Good Health and Well Being ,Animals ,Mice ,Melanoma ,Skin Neoplasms ,GTP-Binding Protein alpha Subunits ,GTP-Binding Protein alpha Subunits ,Gq-G11 ,Drug Evaluation ,Preclinical ,Uveal Neoplasms ,Protein Kinase Inhibitors ,FAK ,GNAQ ,PKC ,PKN/PRK ,chemogenetic drug screening ,combination therapy ,melanoma ,precision medicine ,synthetic lethality ,Biomedical and clinical sciences - Abstract
Uveal melanoma (UM) is the most prevalent cancer of the eye in adults, driven by activating mutation of GNAQ/GNA11; however, there are limited therapies against UM and metastatic UM (mUM). Here, we perform a high-throughput chemogenetic drug screen in GNAQ-mutant UM contrasted with BRAF-mutant cutaneous melanoma, defining the druggable landscape of these distinct melanoma subtypes. Across all compounds, darovasertib demonstrates the highest preferential activity against UM. Our investigation reveals that darovasertib potently inhibits PKC as well as PKN/PRK, an AGC kinase family that is part of the "dark kinome." We find that downstream of the Gαq-RhoA signaling axis, PKN converges with ROCK to control FAK, a mediator of non-canonical Gαq-driven signaling. Strikingly, darovasertib synergizes with FAK inhibitors to halt UM growth and promote cytotoxic cell death in vitro and in preclinical metastatic mouse models, thus exposing a signaling vulnerability that can be exploited as a multimodal precision therapy against mUM.
- Published
- 2023
10. Insights into the Evolution of Longevity from the Bowhead Whale Genome
- Author
-
Michael Keane, Jeremy Semeiks, Andrew E. Webb, Yang I. Li, Víctor Quesada, Thomas Craig, Lone Bruhn Madsen, Sipko van Dam, David Brawand, Patrícia I. Marques, Pawel Michalak, Lin Kang, Jong Bhak, Hyung-Soon Yim, Nick V. Grishin, Nynne Hjort Nielsen, Mads Peter Heide-Jørgensen, Elias M. Oziolor, Cole W. Matson, George M. Church, Gary W. Stuart, John C. Patton, J. Craig George, Robert Suydam, Knud Larsen, Carlos López-Otín, Mary J. O’Connell, John W. Bickham, Bo Thomsen, and João Pedro de Magalhães
- Subjects
Biology (General) ,QH301-705.5 - Abstract
The bowhead whale (Balaena mysticetus) is estimated to live over 200 years and is possibly the longest-living mammal. These animals should possess protective molecular adaptations relevant to age-related diseases, particularly cancer. Here, we report the sequencing and comparative analysis of the bowhead whale genome and two transcriptomes from different populations. Our analysis identifies genes under positive selection and bowhead-specific mutations in genes linked to cancer and aging. In addition, we identify gene gain and loss involving genes associated with DNA repair, cell-cycle regulation, cancer, and aging. Our results expand our understanding of the evolution of mammalian longevity and suggest possible players involved in adaptive genetic changes conferring cancer resistance. We also found potentially relevant changes in genes related to additional processes, including thermoregulation, sensory perception, dietary adaptations, and immune response. Our data are made available online (http://www.bowhead-whale.org) to facilitate research in this long-lived species.
- Published
- 2015
- Full Text
- View/download PDF
11. Collagen peptide supplementation before bedtime reduces sleep fragmentation and improves cognitive function in physically active males with sleep complaints
- Author
-
Thomas, Craig, Kingshott, Ruth N., Allott, Kirsty M., Tang, Jonathan C. Y., Dunn, Rachel, Fraser, William D., Thorley, Josh, Virgilio, Nicolina, Prawitt, Janne, Hogervorst, Eef, Škarabot, Jakob, and Clifford, Tom
- Published
- 2024
- Full Text
- View/download PDF
12. Combined effects of green tea supplementation and eccentric exercise on nuclear factor erythroid 2-related factor 2 activity
- Author
-
Thorley, Josh, Thomas, Craig, Thon, Nicolas, Nuttall, Hannah, Martin, Neil R. W., Bishop, Nicolette, Bailey, Stephen J., and Clifford, Tom
- Published
- 2024
- Full Text
- View/download PDF
13. Comprehensive Cardiovascular Risk Factor Control With a Mobile Health Cardiovascular Risk Self‐Management Program
- Author
-
Edo Paz, Vedant S. Pargaonkar, Brian J. Roach, Morgan Meadows, Jennifer M. Roberts, Tomer Gazit, Amanda L. Zaleski, Kelly Jean Thomas Craig, Steven J. Serra, Pat Dunn, and Erin D. Michos
- Subjects
artificial intelligence ,blood pressure ,cardiovascular diseases ,cholesterol ,heart disease risk factors ,mobile health ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background Mobile health technology's impact on cardiovascular risk factor control is not fully understood. This study evaluates the association between interaction with a mobile health application and change in cardiovascular risk factors. Methods and Results Participants with hypertension with or without dyslipidemia enrolled in a workplace‐deployed mobile health application‐based cardiovascular risk self‐management program between January 2018 and December 2022. Retrospective evaluation explored the influence of application engagement on change in blood pressure (BP), total cholesterol (TC), low‐density lipoprotein cholesterol (LDL‐C), and weight. Multiple regression analyses examined the influence of guideline‐based, nonpharmacological lifestyle‐based digital coaching on outcomes adjusting for confounders. Of 102 475 participants, 49.1% were women. Median age was 53 (interquartile range, 43–61) years, BP was 134 (interquartile range, 124–144)/84 (interquartile range, 78–91) mm Hg, TC was 183 (interquartile range, 155–212) mg/dL, LDL‐C was 106 (82–131) mg/dL, and body mass index was 30 (26–35) kg/m2. At 2 years, participants with baseline systolic BP ≥140 mm Hg reduced systolic BP by 18.6 (SEM, 0.3) mm Hg. At follow up, participants with baseline TC ≥240 mg/dL reduced TC by 65.7 (SEM, 4.6) mg/dL, participants with baseline LDL‐C≥160 mg/dL reduced LDL‐C by 66.6 (SEM, 6.2) mg/dL, and participants with baseline body mass index ≥30 kg/m2 lost 12.0 (SEM, 0.3) pounds, or 5.1% of body weight. Interaction with digital coaching was associated with greater reduction in all outcomes. Conclusions A mobile health application‐based cardiovascular risk self‐management program was associated with favorable reductions in BP, TC, LDL‐C, and weight, highlighting the potential use of this technology in comprehensive cardiovascular risk factor control.
- Published
- 2024
- Full Text
- View/download PDF
14. Markets
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
15. Networks
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
16. Institutions, rules and actors
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
17. Conclusions
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
18. Transition management
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
19. Governing the environment
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
20. Global governance
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
21. Introduction
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
22. Adaptive governance
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
23. Participation and politics
- Author
-
Evans, James, primary and Thomas, Craig, additional
- Published
- 2023
- Full Text
- View/download PDF
24. Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
- Author
-
He, Dan, Feng, Huijin, Sundberg, Belen, Yang, Jiaxing, Powers, Justin, Christian, Alec H, Wilkinson, John E, Monnin, Cian, Avizonis, Daina, Thomas, Craig J, Friedman, Richard A, Kluger, Michael D, Hollingsworth, Michael A, Grandgenett, Paul M, Klute, Kelsey A, Toste, F Dean, Chang, Christopher J, and Chio, Iok In Christine
- Subjects
Biochemistry and Cell Biology ,Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Biological Sciences ,Cancer ,Digestive Diseases ,Pancreatic Cancer ,Rare Diseases ,2.1 Biological and endogenous factors ,Aetiology ,Carcinoma ,Pancreatic Ductal ,Carrier Proteins ,Humans ,Membrane Proteins ,Methionine ,Methionine Sulfoxide Reductases ,Oxidation-Reduction ,Pancreatic Neoplasms ,Pyruvate Kinase ,Thyroid Hormones ,Thyroid Hormone-Binding Proteins ,PKM2 ,cancer metabolism ,glucose oxidation ,metastasis ,methionine oxidation ,pancreatic cancer ,redox signaling ,Medical and Health Sciences ,Developmental Biology ,Biological sciences ,Biomedical and clinical sciences ,Health sciences - Abstract
Cancer mortality is primarily a consequence of its metastatic spread. Here, we report that methionine sulfoxide reductase A (MSRA), which can reduce oxidized methionine residues, acts as a suppressor of pancreatic ductal adenocarcinoma (PDA) metastasis. MSRA expression is decreased in the metastatic tumors of PDA patients, whereas MSRA loss in primary PDA cells promotes migration and invasion. Chemoproteomic profiling of pancreatic organoids revealed that MSRA loss results in the selective oxidation of a methionine residue (M239) in pyruvate kinase M2 (PKM2). Moreover, M239 oxidation sustains PKM2 in an active tetrameric state to promote respiration, migration, and metastasis, whereas pharmacological activation of PKM2 increases cell migration and metastasis in vivo. These results demonstrate that methionine residues can act as reversible redox switches governing distinct signaling outcomes and that the MSRA-PKM2 axis serves as a regulatory nexus between redox biology and cancer metabolism to control tumor metastasis.
- Published
- 2022
25. A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models
- Author
-
Das, Vaskar, Basovich, Michael B., Thomas, Craig J., Kroin, Jeffrey S., Buvanendran, Asokumar, and McCarthy, Robert J.
- Published
- 2024
- Full Text
- View/download PDF
26. Dissecting the gene network of dietary restriction to identify evolutionarily conserved pathways and new functional genes.
- Author
-
Daniel Wuttke, Richard Connor, Chintan Vora, Thomas Craig, Yang Li, Shona Wood, Olga Vasieva, Robert Shmookler Reis, Fusheng Tang, and João Pedro de Magalhães
- Subjects
Genetics ,QH426-470 - Abstract
Dietary restriction (DR), limiting nutrient intake from diet without causing malnutrition, delays the aging process and extends lifespan in multiple organisms. The conserved life-extending effect of DR suggests the involvement of fundamental mechanisms, although these remain a subject of debate. To help decipher the life-extending mechanisms of DR, we first compiled a list of genes that if genetically altered disrupt or prevent the life-extending effects of DR. We called these DR-essential genes and identified more than 100 in model organisms such as yeast, worms, flies, and mice. In order for other researchers to benefit from this first curated list of genes essential for DR, we established an online database called GenDR (http://genomics.senescence.info/diet/). To dissect the interactions of DR-essential genes and discover the underlying lifespan-extending mechanisms, we then used a variety of network and systems biology approaches to analyze the gene network of DR. We show that DR-essential genes are more conserved at the molecular level and have more molecular interactions than expected by chance. Furthermore, we employed a guilt-by-association method to predict novel DR-essential genes. In budding yeast, we predicted nine genes related to vacuolar functions; we show experimentally that mutations deleting eight of those genes prevent the life-extending effects of DR. Three of these mutants (OPT2, FRE6, and RCR2) had extended lifespan under ad libitum, indicating that the lack of further longevity under DR is not caused by a general compromise of fitness. These results demonstrate how network analyses of DR using GenDR can be used to make phenotypically relevant predictions. Moreover, gene-regulatory circuits reveal that the DR-induced transcriptional signature in yeast involves nutrient-sensing, stress responses and meiotic transcription factors. Finally, comparing the influence of gene expression changes during DR on the interactomes of multiple organisms led us to suggest that DR commonly suppresses translation, while stimulating an ancient reproduction-related process.
- Published
- 2012
- Full Text
- View/download PDF
27. A Mission Without Borders: Why a Father and Son Risked it All for the People of Ukraine
- Author
-
Chad Robichaux, David L. Thomas, Craig Borlase and Chad Robichaux, David L. Thomas, Craig Borlase
- Published
- 2024
28. IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
- Author
-
Bolomsky, Arnold, Ceribelli, Michele, Scheich, Sebastian, Rinaldi, Kristina, Huang, Da Wei, Chakraborty, Papiya, Pham, Lisette, Wright, George W., Hsiao, Tony, Morris, Vivian, Choi, Jaewoo, Phelan, James D., Holewinski, Ronald J., Andresson, Thorkell, Wisniewski, Jan, Riley, Deanna, Pittaluga, Stefania, Hill, Elizabeth, Thomas, Craig J., Muppidi, Jagan, and Young, Ryan M.
- Published
- 2024
- Full Text
- View/download PDF
29. Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
- Author
-
Choi, Jaewoo, Ceribelli, Michele, Phelan, James D., Häupl, Björn, Huang, Da Wei, Wright, George W., Hsiao, Tony, Morris, Vivian, Ciccarese, Francesco, Wang, Boya, Corcoran, Sean, Scheich, Sebastian, Yu, Xin, Xu, Weihong, Yang, Yandan, Zhao, Hong, Zhou, Joyce, Zhang, Grace, Muppidi, Jagan, Inghirami, Giorgio G., Oellerich, Thomas, Wilson, Wyndham H., Thomas, Craig J., and Staudt, Louis M.
- Published
- 2024
- Full Text
- View/download PDF
30. A landscape of response to drug combinations in non-small cell lung cancer
- Author
-
Nair, Nishanth Ulhas, Greninger, Patricia, Zhang, Xiaohu, Friedman, Adam A., Amzallag, Arnaud, Cortez, Eliane, Sahu, Avinash Das, Lee, Joo Sang, Dastur, Anahita, Egan, Regina K., Murchie, Ellen, Ceribelli, Michele, Crowther, Giovanna S., Beck, Erin, McClanaghan, Joseph, Klump-Thomas, Carleen, Boisvert, Jessica L., Damon, Leah J., Wilson, Kelli M., Ho, Jeffrey, Tam, Angela, McKnight, Crystal, Michael, Sam, Itkin, Zina, Garnett, Mathew J., Engelman, Jeffrey A., Haber, Daniel A., Thomas, Craig J., Ruppin, Eytan, and Benes, Cyril H.
- Published
- 2023
- Full Text
- View/download PDF
31. Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex
- Author
-
Sun, Yilun, Baechler, Simone A., Zhang, Xiaohu, Kumar, Suresh, Factor, Valentina M., Arakawa, Yasuhiro, Chau, Cindy H., Okamoto, Kanako, Parikh, Anup, Walker, Bob, Su, Yijun P., Chen, Jiji, Ting, Tabitha, Huang, Shar-yin N., Beck, Erin, Itkin, Zina, McKnight, Crystal, Xie, Changqing, Roper, Nitin, Nijhawan, Deepak, Figg, William Douglas, Meltzer, Paul S., Yang, James C., Thomas, Craig J., and Pommier, Yves
- Published
- 2023
- Full Text
- View/download PDF
32. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma
- Author
-
Lang, Martin, Schmidt, Laura S., Wilson, Kelli M., Ricketts, Christopher J., Sourbier, Carole, Vocke, Cathy D., Wei, Darmood, Crooks, Daniel R., Yang, Youfeng, Gibbs, Benjamin K., Zhang, Xiaohu, Klumpp-Thomas, Carleen, Chen, Lu, Guha, Rajarshi, Ferrer, Marc, McKnight, Crystal, Itkin, Zina, Wangsa, Darawalee, Wangsa, Danny, James, Amy, Difilippantonio, Simone, Karim, Baktir, Morís, Francisco, Ried, Thomas, Merino, Maria J., Srinivasan, Ramaprasad, Thomas, Craig J., and Linehan, W. Marston
- Published
- 2023
- Full Text
- View/download PDF
33. The impact of external innovation on new drug approvals: A retrospective analysis
- Author
-
Liu, Xiong, Thomas, Craig E., and Felder, Christian C.
- Subjects
Computer Science - Computation and Language ,Computer Science - Computers and Society ,Quantitative Biology - Quantitative Methods - Abstract
Pharmaceutical companies are relying more often on external sources of innovation to boost their discovery research productivity. However, more in-depth knowledge about how external innovation may translate to successful product launches is still required in order to better understand how to best leverage the innovation ecosystem. We analyzed the pre-approval publication histories for FDA-approved new molecular entities (NMEs) and new biologic entities (NBEs) launched by 13 top research pharma companies during the last decade (2006-2016). We found that academic institutions contributed the majority of pre-approval publications and that publication subject matter is closely aligned with the strengths of the respective innovator. We found this to also be true for candidate drugs terminated in Phase 3, but the volume of literature on these molecules is substantially less than for approved drugs. This may suggest that approved drugs are often associated with a more robust dataset provided by a large number of institutes. Collectively, the results of our analysis support the hypothesis that a collaborative research innovation environment spanning across academia, industry and government is highly conducive to successful drug approvals.
- Published
- 2021
- Full Text
- View/download PDF
34. The show must go on. Reply to “Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al” by Insop Shim
- Author
-
Bonaventura, Jordi, Lam, Sherry, Carlton, Meghan, Boehm, Matthew, Gomez, Juan L., Solís, Oscar, Sánchez-Soto, Marta, Morris, Patrick J., Fredriksson, Ida, Thomas, Craig J., Sibley, David R., Shaham, Yavin, Zarate, Jr., Carlos A., and Michaelides, Michael
- Published
- 2023
- Full Text
- View/download PDF
35. Understanding user experience of in-vehicle noise based on road surface texture data
- Author
-
Andriejauskas, Tadas, primary, Wright, Alex, additional, Lee, Rob, additional, Thomas, Craig, additional, McRobbie, Stuart, additional, and Mbah, Neng, additional
- Published
- 2023
- Full Text
- View/download PDF
36. Improving the understanding of user experience of ride quality
- Author
-
Thomas, Craig, primary, Wright, Alex, additional, Nesnas, Kamal, additional, Dhillon, Nathan, additional, Mbah, Neng, additional, and McRobbie, Stuart, additional
- Published
- 2023
- Full Text
- View/download PDF
37. Comprehensiveness, Accuracy, and Readability of Exercise Recommendations Provided by an AI-Based Chatbot: Mixed Methods Study
- Author
-
Amanda L Zaleski, Rachel Berkowsky, Kelly Jean Thomas Craig, and Linda S Pescatello
- Subjects
Special aspects of education ,LC8-6691 ,Medicine (General) ,R5-920 - Abstract
BackgroundRegular physical activity is critical for health and disease prevention. Yet, health care providers and patients face barriers to implement evidence-based lifestyle recommendations. The potential to augment care with the increased availability of artificial intelligence (AI) technologies is limitless; however, the suitability of AI-generated exercise recommendations has yet to be explored. ObjectiveThe purpose of this study was to assess the comprehensiveness, accuracy, and readability of individualized exercise recommendations generated by a novel AI chatbot. MethodsA coding scheme was developed to score AI-generated exercise recommendations across ten categories informed by gold-standard exercise recommendations, including (1) health condition–specific benefits of exercise, (2) exercise preparticipation health screening, (3) frequency, (4) intensity, (5) time, (6) type, (7) volume, (8) progression, (9) special considerations, and (10) references to the primary literature. The AI chatbot was prompted to provide individualized exercise recommendations for 26 clinical populations using an open-source application programming interface. Two independent reviewers coded AI-generated content for each category and calculated comprehensiveness (%) and factual accuracy (%) on a scale of 0%-100%. Readability was assessed using the Flesch-Kincaid formula. Qualitative analysis identified and categorized themes from AI-generated output. ResultsAI-generated exercise recommendations were 41.2% (107/260) comprehensive and 90.7% (146/161) accurate, with the majority (8/15, 53%) of inaccuracy related to the need for exercise preparticipation medical clearance. Average readability level of AI-generated exercise recommendations was at the college level (mean 13.7, SD 1.7), with an average Flesch reading ease score of 31.1 (SD 7.7). Several recurring themes and observations of AI-generated output included concern for liability and safety, preference for aerobic exercise, and potential bias and direct discrimination against certain age-based populations and individuals with disabilities. ConclusionsThere were notable gaps in the comprehensiveness, accuracy, and readability of AI-generated exercise recommendations. Exercise and health care professionals should be aware of these limitations when using and endorsing AI-based technologies as a tool to support lifestyle change involving exercise.
- Published
- 2024
- Full Text
- View/download PDF
38. A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants
- Author
-
Johnson Barry C, Pauly Gary T, Rai Ganesha, Patel Disha, Bauman Joseph D, Baker Heather L, Das Kalyan, Schneider Joel P, Maloney David J, Arnold Eddy, Thomas Craig J, and Hughes Stephen H
- Subjects
HIV ,Reverse transcriptase ,Rilpivirine ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Abstract Background The recently approved anti-AIDS drug rilpivirine (TMC278, Edurant) is a nonnucleoside inhibitor (NNRTI) that binds to reverse transcriptase (RT) and allosterically blocks the chemical step of DNA synthesis. In contrast to earlier NNRTIs, rilpivirine retains potency against well-characterized, clinically relevant RT mutants. Many structural analogues of rilpivirine are described in the patent literature, but detailed analyses of their antiviral activities have not been published. This work addresses the ability of several of these analogues to inhibit the replication of wild-type (WT) and drug-resistant HIV-1. Results We used a combination of structure activity relationships and X-ray crystallography to examine NNRTIs that are structurally related to rilpivirine to determine their ability to inhibit WT RT and several clinically relevant RT mutants. Several analogues showed broad activity with only modest losses of potency when challenged with drug-resistant viruses. Structural analyses (crystallography or modeling) of several analogues whose potencies were reduced by RT mutations provide insight into why these compounds were less effective. Conclusions Subtle variations between compounds can lead to profound differences in their activities and resistance profiles. Compounds with larger substitutions replacing the pyrimidine and benzonitrile groups of rilpivirine, which reorient pocket residues, tend to lose more activity against the mutants we tested. These results provide a deeper understanding of how rilpivirine and related compounds interact with the NNRTI binding pocket and should facilitate development of novel inhibitors.
- Published
- 2012
- Full Text
- View/download PDF
39. Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML
- Author
-
Bennett, Joshua, Ishikawa, Chiharu, Agarwal, Puneet, Yeung, Jennifer, Sampson, Avery, Uible, Emma, Vick, Eric, Bolanos, Lyndsey C., Hueneman, Kathleen, Wunderlich, Mark, Kolt, Amal, Choi, Kwangmin, Volk, Andrew, Greis, Kenneth D., Rosenbaum, Jan, Hoyt, Scott B., Thomas, Craig J., and Starczynowski, Daniel T.
- Published
- 2023
- Full Text
- View/download PDF
40. Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma
- Author
-
Peat, Tyler J., Gaikwad, Snehal M., Dubois, Wendy, Gyabaah-Kessie, Nana, Zhang, Shuling, Gorjifard, Sayeh, Phyo, Zaw, Andres, Megan, Hughitt, V. Keith, Simpson, R. Mark, Miller, Margaret A., Girvin, Andrew T., Taylor, Andrew, Williams, Daniel, D'Antonio, Nelson, Zhang, Yong, Rajagopalan, Adhithi, Flietner, Evan, Wilson, Kelli, Zhang, Xiaohu, Shinn, Paul, Klumpp-Thomas, Carleen, McKnight, Crystal, Itkin, Zina, Chen, Lu, Kazandijian, Dickran, Zhang, Jing, Michalowski, Aleksandra M., Simmons, John K., Keats, Jonathan, Thomas, Craig J., and Mock, Beverly A.
- Published
- 2023
- Full Text
- View/download PDF
41. Sport, social class and the inter-war BBC, 1922-39 : a study of Reithian employment policies through the social theory of Pierre Bourdieu
- Author
-
Thomas, Craig
- Abstract
This thesis explores the history of BBC radio sport from the founding of the monopoly broadcasting company in 1922 to the end of 1939 from the perspective of social class. The sociological thought of Pierre Bourdieu is applied as a tool of analysis throughout. The work first uncovers a Reithian system of staff recruitment based on the possession by individuals of accumulated social and cultural capital, principally via attendance at public schools and Oxford or Cambridge universities. Then, via a rigorous investigation of personal biographies, archival documents held at the BBC Written and Sound Archive, staff memoirs, Radio Times articles and programme notes, the thesis demonstrates the extended nature of this system in the realm of BBC radio sports output at both national and regional levels. As it traces its path through the 1920s and 1930s in a study of continuity and change, it finds that only minor alterations were made to the system by the outbreak of the Second World War. The inclusion of a case study of the first live sports running commentary in January 1927 points up the definitively elitist social processes at work in constructing BBC sports programming.
- Published
- 2020
42. Internal dynamics of coalescing droplets
- Author
-
Sykes, Thomas Craig, Wilson, Mark C. T., Harbottle, David, Khatir, Zinedine, and Thompson, Harvey M.
- Subjects
620.1 - Abstract
Internal flows determine the extent of advective mixing (stretching and folding of fluid interfaces) between coalescing droplets, effectively defining the initial condition for molecular diffusion to homogenise the fluid. Efficient mixing is essential in applications from inkjet printing to microfluidic devices, especially where a chemical reaction or biological process occurs between the droplet fluids. In emerging technologies, coalescing droplets often have different fluid properties, are in contact with a substrate and are surrounded by gas. An improved fundamental understanding of the internal dynamics in such cases, as contributed by this work, is both of significant physical interest and essential for improving mixing efficiency in applications. This combined numerical and experimental work considers surface-tension-dominated coalescing droplets in two primary configurations: initially-static free and sessile droplets; impacting and sessile droplets with varied lateral separation. Two high-speed imaging experimental setups were designed and constructed, including one featuring synchronised colour cameras yielding simultaneous front and bottom views. A quantitatively-validated customised numerical simulation code was developed within OpenFOAM, utilising the Kistler dynamic contact angle model (including contact angle hysteresis) to capture substrate wettability and a conserved passive scalar to assess advective mixing. The conditions leading to the formation of internal and surface jets between coalescing droplets are determined, where jet formation can significantly improve mixing efficiency. In particular, the effect of substrate wettability (principally via capillary waves) and fluid properties on internal flows are systematically studied in tandem. A mechanism of internal jet formation between free and sessile coalescing droplets, at volume ratios very different from those accepted for free droplets, is identified. A mechanism of surface jet formation between impacting and sessile droplets with a large lateral separation is elucidated, in which jet formation and mixing is controlled via Marangoni flow for droplets of different surface tension. Moreover, it is shown that diffusive mixing can be passively assessed via colour-change reactions, which are in turn used to identify efficient mixing mechanisms.
- Published
- 2020
43. Preclinical validation of a novel therapeutic strategy for choroid plexus carcinoma
- Author
-
Martin, Brice, Garman, Tyler, Laramee, Madeline, Wang, Amy, Zhang, Xiaohu, Beck, Erin, Wilson, Kelli, Klumpp-Thomas, Carleen, McKnight, Crystal, Xu, Xin, Hagen, Natalie, Holland, David, Dahmane, Nadia, Thomas, Craig J., and Souweidane, Mark
- Published
- 2023
- Full Text
- View/download PDF
44. Racial and Ethnic Differences in Social Determinants of Health and Health-Related Social Needs Among Adults--Behavioral Risk Factor Surveillance System, United States, 2022
- Author
-
Town, Machell, Eke, Paul, Zhao, Guixiang, Thomas, Craig W., Hsia, Jason, Pierannunzi, Carol, and Hacker, Karen
- Subjects
United States. Centers for Disease Control and Prevention ,Medical research ,Medicine, Experimental ,Adults ,Type 2 diabetes -- Risk factors ,Native Americans ,African Americans ,Health - Abstract
Introduction Social determinants of health (SDOH) are the nonmedical factors that influence health outcomes. They are the conditions in which persons are born, live, learn, work, play, worship, and age [...]
- Published
- 2024
45. Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search
- Author
-
Bonaventura, Jordi, Gomez, Juan L., Carlton, Meghan L., Lam, Sherry, Sanchez-Soto, Marta, Morris, Patrick J., Moaddel, Ruin, Kang, Hye Jin, Zanos, Panos, Gould, Todd D., Thomas, Craig J., Sibley, David R., Zarate, Jr., Carlos A., and Michaelides, Michael
- Published
- 2022
- Full Text
- View/download PDF
46. Creative workers' perception of place in Edmonton Canada
- Author
-
Thomas, Craig
- Published
- 2023
- Full Text
- View/download PDF
47. Contesting urban fracking in Greater Manchester : opening a political space in an urban terrain of protest
- Author
-
Thomas, Craig, Castree, Noel, and Evans, James
- Subjects
550 ,dissent ,social movements ,environmental ,radical politics ,post-politics ,struggle ,post-foundational ,Barton Moss ,community ,local ,protest ,urban ,subjectivation ,shale gas ,neoliberalisation ,fracking ,political ,politics ,Rancie`re ,Manchester ,Salford ,Greater Manchester ,anti-fracking ,subjectification - Abstract
This thesis is the first to focus on grassroots political opposition to fracking development in a city-region. It examines the political space opened by activists in Greater Manchester between 15th November 2013 and 12th April 2014, situating their political struggle in a broader urban terrain of protest. Data collection was conducted between 28th August 2013 and 20th October 2014. The thesis looks beyond simple interpretations of community opposition, toward theoretically grounded understandings of anti-fracking dissent. Paradoxically, in this case a local struggle emerged primarily from social movements unrelated to the development site itself, whose actors converged on the issue of stopping fracking in the cityregion and engaged disadvantaged communities neighbouring the exploratory well. Research illustrates how activists drew on the tactics and organisational practices of radical urban uprisings to open-up and sustain an anti-fracking camp outside the exploratory well for five months, and examines ways that their dissent challenged what was being contested, who could engage in the struggle and which grievances were recognised as legitimate. Understanding the complexities of the struggle contributes to existing research on the politics of contemporary urban environmental movements by examining how solidarity and an emancipatory politics can emerge from disparate groups that have seemingly discordant perspectives. This has practical as well as theoretical relevance, because the Greater Manchester anti-fracking movement successfully presented a united front against 'fracking', despite internal conflict between actors. Using ostensibly horizontal and less-obvious vertical organisational modes of practice to organise the anti-fracking movement, activists sustained a protest camp and limited access to the exploratory well while it was in operation, before leaving of their own volition. This means that analysis contributes to a politics of hope, offering lessons for similar struggles that emerge from disparate, autonomous groups.
- Published
- 2019
48. Rights intrusion and land use planning inequalities in Alberta’s summer villages
- Author
-
Thomas, Craig, primary
- Published
- 2024
- Full Text
- View/download PDF
49. Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
- Author
-
Moaddel, Ruin, Zanos, Panos, Farmer, Cristan A., Kadriu, Bashkim, Morris, Patrick J., Lovett, Jacqueline, Acevedo-Diaz, Elia E., Cavanaugh, Grace W., Yuan, Peixiong, Yavi, Mani, Thomas, Craig J., Park, Lawrence T., Ferrucci, Luigi, Gould, Todd D., and Zarate, Jr, Carlos A.
- Published
- 2022
- Full Text
- View/download PDF
50. Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma
- Author
-
Pahwa, Roma, Dubhashi, Janhavi, Singh, Anand, Jailwala, Parthav, Lobanov, Alexei, Thomas, Craig J., Ceribelli, Michele, Wilson, Kelli, Ricketts, Christopher J., Vocke, Cathy D., Wells, Catherine, Bottaro, Donald P., Linehan, W. Marston, Neckers, Len, and Srinivasan, Ramaprasad
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.